SWEDEN-HEALTH-VIRUS-VACCINES-ASTRAZENECA

Vials of a test production are pictured at the assembly line of the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZenecas new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) (Photo by JONATHAN NACKSTRAND/AFP via Getty Images)
Vials of a test production are pictured at the assembly line of the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZenecas new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) (Photo by JONATHAN NACKSTRAND/AFP via Getty Images)
SWEDEN-HEALTH-VIRUS-VACCINES-ASTRAZENECA
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
JONATHAN NACKSTRAND / Contributor
Editorial #:
1238317963
Collection:
AFP
Date created:
February 08, 2022
Upload date:
License type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_9YY7Z3
Max file size:
4915 x 3270 px (16.38 x 10.90 in) - 300 dpi - 4 MB